Stigma resistance among people with schizophrenia at Amanuel Mental Specialized Hospital Addis Ababa, Ethiopia: a cross-sectional institution based study by Berhanu Boru Bifftu et al.
Bifftu et al. BMC Psychiatry 2014, 14:259
http://www.biomedcentral.com/1471-244X/14/259RESEARCH ARTICLE Open AccessStigma resistance among people with
schizophrenia at Amanuel Mental Specialized
Hospital Addis Ababa, Ethiopia: a cross-sectional
institution based study
Berhanu Boru Bifftu1*, Berihun Assefa Dachew2 and Bewket Tadesse Tiruneh1Abstract
Background: Schizophrenia is one of the most disabling and severely stigmatized mental disorders. Together with
social stigma, internalized stigma and perceived stigma can trigger a vicious cycle and diminishes the stigma
resistance abilities of individual. Helping patients to cope up with perceived and internalized stigma play crucial
role in fighting stigma. This study aimed to assess the prevalence and associated factors of stigma resistance
among people with schizophrenia attending the outpatient department of Amanuel Mental Specialized Hospital,
Addis Ababa, Ethiopia.
Methods: Institution based cross-sectional study design was employed. Single population proportion formula was
used to calculate sample size. Subjects were selected by systematic sampling techniques. Bivariate and multivariate
logistic regressions were performed to identify the presence and strength of association. Odds ratios with 95%
confidence interval were computed to determine the level of significance.
Results: A total of 411 subjects participated in the study giving a response rate of 97.4%. The prevalence of low
stigma resistance was found to be 51.6%. Rural residence (AOR = 0.29 (95% CI: 0.142, 0.594), difficulties of adherence
to antipsychotic medication (AOR = AOR = 0.3, 95% CI: 0.155, 0.542), internalized stigma (AOR = 0.24, 95% CI: (0.111,
0.530), alienation (AOR = 0.5, 95% CI: (0.270, 0.927), stereotype endorsement (AOR = 0.37(95% CI: 0.312, 0.463) and
social withdrawal (AOR = 0.27, 95% CI: (0.156, 0.468) were factors statistically associated with low stigma resistance.
Conclusion: In this study, overall more than half of the study participants had low stigma resistance. Rural
residence, difficulties of adherence to antipsychotic medication, high internalized stigma, alienation and social
withdrawal were factors statistically associated with low stigma resistance. Encouraging participations in different
social relationships such as befriending programs, family and peer support groups are recommended.
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Schizophrenia is one of the most disabling and severely
stigmatized mental disorder, which was selected as the
central focus of the World Psychiatric Association’s glo-
bal anti-stigma programme entitled ‘Open the Doors’
[1]. Stigma is common [2,3] and remains a major burden* Correspondence: berhanuboru@gmail.com
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unless otherwise stated.for individuals with psychiatric disorders [4,5], their fam-
ilies [6,7] and caregivers [8].
Stigmatizing attitudes towards people with mental
illness such as: beliefs that people with mental illness are
dangerous, cannot recover, or cannot contribute to
society can lead them to internalize these stigmatizing
beliefs and affects many domains of their lives such as
self-esteem [9], prolong recovery [10,11] social relation-
ships [10,12], treatment adherence and willingness to
seek help [9], persistent suffering, disability and economic
loss [13], difficulties of access housing and employmenttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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internalized stigma and perceived stigma can trigger a vi-
cious cycle and diminishes the stigma resistance abilities
of individuals [14-16].
In order to overcome such problem, concerted efforts
based on local evidence are required. A systematic litera-
ture review was conducted to identify stigma reduction
strategies and interventions in the field of mental illness
[16,17]. The review identified several levels at which in-
terventions and strategies are being implemented. These
are the intrapersonal (those focus on addressing inter-
nalized and anticipated stigma), interpersonal (those af-
fecting intimate groups of people: friends, family, work
and social networks), institutional (those that targeting
the institutions particular relevance to stigmatized people:
e.g. health care providers or police officers, community
and governmental/structural are also involved in a variety
of intervention such as training, education, media cam-
paigns and contact people with mental illness, or combi-
nations of these strategies [16-19].
Although a lot of work has been carried out on
stigma by developing stigma reduction strategies, far
less work has been done to assess the effectiveness of
these stigma reduction strategies. The effective strat-
egies identified mainly concentrated on the individual
and the community level [18,19]. In order to reduce
health-related stigma and discrimination significantly,
single level and single target group approaches are not
enough. Rather it required patient-centered approaches
that target the intrapersonal level, to empower affected
persons to assist the development and implementation
of stigma reduction programs [20-22]. That is why the
authors interested to identify the stigma resistance level
of those patients.
Until a few years ago, the focus of most research was
on investigation of stigma in people with schizophrenia
through surveys of the general public’s attitudes and the
stigma that people experienced after being diagnosed
with a mental illness (internalized stigma) [16] or indi-
vidual’s perceptions, or anticipation of negative social
reaction (perceived stigma) rather than the stigma resist-
ance ability of the patient. On the other hand, most of
the researchers have been recommended to move on the
alternative foci of research that is stigma resistance (SR).
Stigma resistance is an individual’s capacity to counter-
act the stigma of mental illness [22,23].
Helping patients to cope with perceived and or inter-
nalized stigma especially building up of the stigma resist-
ance ability of people with mental illness play crucial
role in fighting stigma and help individuals in their hope
of finding a fulfilling life in their recovery from mental
illness and stigma because different literature revealed
the importance of SR is positively associated with self-
esteem, empowerment, and quality of life and negativelywith stigma measures [23]. However, until now, stigma
resistance has not been explicitly studied; the few avail-
able studies from Western demonstrated its importance.
In developing countries, particularly in Ethiopia there
is no previous study reported on stigma resistance of
people with schizophrenia. The only published study
concerning stigma among individuals with schizophrenia
was internalized stigma [24]. Therefore, the present
study aimed to assess the stigma resistance ability of in-
dividuals with schizophrenia and its associated factors.
Methods
Study design
Institution based cross-sectional study design was employed.
Study area and period
The study was conducted from March to April 2012 at
Amanuel Mental Specialized Hospital (AMSH). AMSH
was established in 1930 and is situated in Addis Ababa,
the capital city of Ethiopia. It is the only mental health
hospital in the country. The hospital has a total of 300
beds of which 277 are for inpatients and 23 are Emer-
gency beds. There is also a large out-patient service,
with around 115,000 visiting outpatients department
each year.
Participants
The participants of this study were individuals with schizo-
phrenia receiving follow-up care at the outpatient depart-
ment of Amanuel Mental Health Specialized Hospital.
Single population proportion formula (with the assump-
tion of 5% margin of error, 95% confidence level and
50% proportion) was used to calculate sample size; and
it was found to be 422 (including 10% non response
rate). The total number of patients who visited the hos-
pital for the last 12 months were taken from patient re-
cords and then the average number of patients per day
calculated. Participants were selected by systematic ran-
dom sampling technique. All individuals with a clinical
diagnosis of schizophrenia coming for follow up with an
age greater than or equal to 18 years were included. In-
dividuals with schizophrenia who were unable to speak,
hear and have no insight were excluded from the study.
Instrument
Stigma resistance was investigated using the SR subscale
of the internalized stigma of mental illness (ISMI) scale
which was developed by Isomippoan [25] in close collab-
oration with members of the target population. ISMI is a
four-point anchored Likert scale consisting of 29 items
tool grouped into five subscales reflecting stigma resist-
ance, alienation, stereotype endorsement, perceived dis-
crimination and social withdrawal. The stigma resistance
subscale, with five items, measures a person’s ability to
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ation subscale, with six items, measures the subjective ex-
perience of being less than a full member of society. The
stereotype endorsement subscale, with seven items, mea-
sures the degree to which respondents agreed with com-
mon stereotypes about people with a mental illness. The
discrimination experience subscale, with five items, mea-
sures respondents’ perceptions of the way they tend to be
treated by others. The social withdrawal subscale, with six
items, measures aspects of social withdrawal.
All items of ISMI were measured on a 4-point Likert-
type agreement scale (1 = strongly disagree to 4 = strongly
agree) were widely used across the world including Africa.
The prevalence of SR was determined using the mean
score of SR items greater than or equal to 2.5 as cutoff
point for high stigma resistance and less than 2.5 for low
SR. High internalized stigma defined on an item mean
score of 2.5 or higher as cutoff point on 4 ISMI sub scales
(SR subscale excluded). Prevalence of high alienation,
stereotype endorsement, perceived discrimination and so-
cial withdrawal were also examined on their mean score
of 2.5 or higher as cutoff point. This cutoff point was also
used previously [23,25].
Furthermore, we asked two questions on antipsychotic
medication adherence and difficulties of patients’ adher-
ence to their clinic appointments (follow up). The anti-
psychotic medication adherence question asked about
history of non-adherence with antipsychotic medications
and whether the non adherence behavior was linked to
low stigma resistance with yes/no response. Specifically
asked questions “Have you ever discontinued your anti-
psychotic medication because of fear of stigma associated
with your mental illness”? “Have you ever discontinued
your clinic appointments (follow up) because of fear of
stigma associated with your mental illness”?
Data collection and analysis
Data were collected by face-to-face interview using pre-
tested, semi-structured questionnaire consisting the
socio-demographic, clinical and internalized stigma of
mental illness scale questionnaires. The questionnaire
translated into an Amharic and then translated back
into English.
Data were coded and entered into EPI info version
3.5.3 statistical software and then exported to SPSS
windows version 16 program for analysis. Descriptive
statistics (frequencies, tables, percentages, means and
standard deviation) were used for the socio-demographic
and clinical variables including individual’s response
to ISMI scale. Binary logistic regression and odds ratio
with 95% confidence interval were used to identify the
associated factors of stigma resistance. A significance
level of 0.05 was taken as cut off value for all statistical
significance tests.Ethical consideration
The study proposal was initially approved by the ethical
review board of The University of Gondar and Amanuel
Mental Specialized Hospital. A formal letter of permis-
sion was obtained from the hospital and submitted to
the respective outpatient department. The information
about the study was given to the participants. Written
informed consent was sought for each participant who
voluntary and fulfilled the inclusion criteria. Only an-
onymous data collected in private rooms.
Results
A total of 411 participants participated in the study with
97.4% response rate. One of the participants failed to
complete the interview because of the illness and nine
questioners were not fulfilled properly.
Socio-demographic characteristics
The majority of the participants were males 302 (73.5%).
The mean (+SD) age was 33.24 (± 9.73 years. Two hun-
dred and eighty nine (70.3%) of the participants were
primary educated, 240 (58.4%) were Orthodox Christian
followers and 286 (69.6%) were single in marital status.
One hundred and six (35.5%) of the participants were
Amhara in Ethnicity. Out of 411 participants, 257 (62.5%)
were unemployed, 322 (78.3%) were living in urban areas
and 360 (87.6%) were living with their families (Table 1).
Clinical characteristics
Regarding the clinical characteristics of participants, 117
(28.5%) were treated for 2–5 years, 204 (49.6%) had ≤1 years
duration of illness, 82 (20%) faced difficulties attending
clinic, 64 (15.6%) were not adhere to their antipsychotic
medication (Table 2).
Prevalence of stigma resistance
Overall, 212 (51.6%) of the study participants had low
stigma resistance. Regarding each items of stigma resist-
ance, the majority 382 (92.9%) of the participants were
agreed or strongly agreed with the item “people with
mental illness make important contributions to society”
(Table 3). The overall mean internalized stigma and in-
ternalized stigma subscales were: internalized stigma
2.45, alienation 2.49, stereotype endorsement 2.36, dis-
crimination experience 2.45, social withdrawal 2.48, and
stigma resistance 2.52. Prevalence of high internalized
stigma, high alienation, high stereotype endorsement,
high experienced discrimination and high social with-
drawal were found to be: 48.6, 57.7, 43.6, 45.7 and 52.3
respectively.
Factors associated with stigma resistance
Bivariante and Multivariate regression analysis were per-
formed to explore the association of socio-demographic,
Table 1 Socio-demographic characteristics of participants
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Table 2 Distribution of participants (n = 411) by their
clinical characteristics at Amanuel Mental Specialized
Hospital, 2012
Characteristics Frequency Percent










Difficulties of adherence to follow up
Yes 82 20
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stigma resistance. From the bivariate analysis: residence,
living arrangement, difficulties of adherence to anti-
psychotic medication, difficulties of adherence to follow
up, internalized stigma, alienation, stereotype endorse-
ment and social withdrawal were factors associated with
low stigma resistance and entered in multivariate logistic
regression for further analysis (Table 4).From the multivariate analysis; rural residence (AOR =
0.29 (95% CI: 0.142, 0.594), difficulties of adherence to
antipsychotic medication (AOR =AOR = 0.3, 95% CI:
(0.155, 0.542)), internalized stigma (AOR = 0.24, 95% CI:
(0.111, 0.530)), alienation (AOR = 0.5, 95% CI: (0.270,
0.927)), stereotype endorsement (AOR = 0.37 (95% CI:
0.312, 0.463)) and social withdrawal (AOR = 0.27, 95% CI:
(0.156, 0.468)) were factors statistically associated with
low stigma resistance (Table 4).
Discussion
The aim of this study was to assess the prevalence and
associated factors of stigma resistance among people
with schizophrenia at Amanuel Mental Specialized Hos-
pital. Overall, the prevalence of low stigma resistance
was found to be 51.6%. This figure is lower than the
study carried out in Europe that reported a prevalence
rate of 67.5% [26]. This variation may be due to the fact
that in this study all of the study participants were re-
cruited from the outpatient department where as in the
study reported in Europe less than half of the study par-
ticipants were recruited from outpatient departments
and the remaining study subjects were recruited from
inpatient and day care clinic. This may indicate that out-
patient individuals with schizophrenia may have higher
stigma resistance than inpatient. The other possible ex-
planations may be due to sample sizes difference, the
population surveyed and the setting.
Table 3 Distribution of participants (n = 411) by their response to internalized stigma of mental illness scale at
Amanuel Mental Specialized Hospital, 2012
Items of ISMI subscale Strongly disagree Disagree Agree Strongly agree
N (%) N (%) N (%) N (%)
Alienation
I feel out of place in the world because I have a mental illness 18(4.4) 243(59.1) 141(34.3) 9(2.2)
I am embarrassed or ashamed that I have a mental illness 22(5.4) 171(41.6) 196(47.6) 22(5.4)
I feel inferior to others who don’t have a mental illness 5(1.2) 204(49.6) 181(44) 21(5.1)
I am disappointed in myself for having a mental illness 7(1.7) 172(41.8) 205(49.9) 27(6.6)
People without mental illness could not possibly understand me 7(1.7) 260(63.3) 131(31.9) 13(3.2)
Having a mental illness has spoiled my life. 4(1) 197(49.9) 169(41.1) 41(10)
Stereotype endorsement
Stereotypes about the mentally ill apply to me 8(1.9) 96(23.4) 294(71.5) 13(3.2)
I can’t contribute anything to society because I have a mental illness 25(6.1) 341(83) 42(10.2) 3(0.7)
Because I have a mental illness, I need others to make most decisions for me 33(8) 298(72.5) 74(18) 6(1.5)
People can tell that I have a mental illness by the way I look 30(7.3) 202(49.1) 163(39.7) 16(3.9)
People with mental illness cannot live a good, rewarding life 14(3.4) 285(69.3) 98(23.8) 14(3.4)
Mentally ill people tend to be violent 5(1.2) 76(18.5) 309(75.2) 21(5.1)
Mentally ill people shouldn’t get married 68(16.5) 277(67.4) 62(15.1) 4(1)
Discrimination experience
People often patronize me, or treat me like a child, just because I have a mental illness 30(7.3) 202(49.1) 170(41.4) 9(2.2)
People ignore me or take me less seriously just because I have a mental illness 18(4.4) 185(45) 193(47) 15(3.6)
Others think that I can’t achieve much in life because I have a mental illness 14(3.4) 156(38) 233(56.7) 8(1.9)
Nobody would be interested in getting close to me because I have a mental illness 20(4.9) 263(64) 122(29.7) 6(1.5)
People discriminate against me because I have a mental illness 15(3.6) 205(49.9) 163(39.7) 28(6.8)
Social withdrawal
I stay away from social situations in order to protect my family or friends from
embarrassment
11(2.7) 237(57.7) 158(38.4) 5(1.2)
Being around people who don’t have a mental illness makes me feel out of place
or inadequate
16(3.9) 230(56) 160(38.9) 5(1.2)
I don’t socialize as much as I used to because my mental illness might make me
look or behave “weird”
11(2.7) 184(44.8) 210(51.1) 6(1.5)
I avoid getting close to people who don’t have a mental illness to avoid rejection 9(2.2) 210(51.1) 189(46) 3(0.7)
I don’t talk about myself much because I don’t want to burden others with my
mental illness
5(1.2) 185(45) 215(52.3) 6(1.5)
Negative stereotypes about mental illness keep me isolated from the “normal” world 10(2.4) 153(37.2) 218(53) 30(7.3)
Stigma resistance
I feel comfortable being seen in public with an obviously mentally ill person 16(3.9) 161(39.2) 210(51.1) 24(5.8)
People with mental illness make important contributions to society 3(0.8) 26(6.4) 363(88.2) 19(4.6)
Living with mental illness has made me a tough survivor 12(2.9) 210(51.1) 176(42.8) 13(3.2)
In general, I am able to live my life the way I want to 26(6.3) 249(60.6) 129(31.4) 7(1.7)
I can have a good, fulfilling life, despite my mental illness 25(6.1) 244(59.4) 140(34) 2(0.5)
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this study (51.6%) is higher than the study reported by
Sibitz et al. from Europe (36.7%) [23]. This variation may
be due to in our study all of the study participants were
confirmed schizophrenic patient who were on follow up,where as in the study reported by Sibitz et al. one third of
the study participants were individuals with schizoaffective
disorder. This may indicate that individual with schizoaf-
fective disorder have higher stigma resistance than individ-
ual with schizophrenia. However, the prevalence of low
Table 4 Factors associated with stigma resistance (bivariate and multivariate) analysis, at Amanuel Mental Specialized
Hospital, 2012
Explanatory variables Stigma resistance COR (95% CI) AOR (95% CI) p-value
Hign N (%) Low N (%)
Residence 0.001
Rural 33(8) 56(13.6) 0.55(0.342, 0.897) 0.29(0.142, 0.594)
Urban 166(40.4) 156(38) 1 1
Living arrangement
With family 162(39.4) 198(48.2) 0.31(1.688, 6.182) ——
Alone 37(9) 14(3.4) 1 1
Difficulties of adherence to follow up
Yes 51(12.5) 31(7.5) 2.01(0.303, 0.817) ——
No 148(36) 181(44) 1 1
Difficulties of adherence to antipsychotic medication
Yes 40(9.7) 24(5.9) 1.97(0.293, 0.878) 0.3(0.155, 0.542) <0.001
No 159(38.7) 188(45.7) 1 1
Internalized stigma
High 118(28.7) 81(19.7) 1.48(0.240, 0.534) 0.24(0.111, 0.530) 0.001
Low 105(25.6) 107(26) 1 1
Alienation
High 105(25.5) 132(32.1) 0.68(0.457, 1.003) 0.5(0.270, 0.927) 0.044
Low 94(22.9) 80(19.5) 1 1
Stereotype endorsement
High 85(20.7) 94(22.9) 0.94(0.456, 0.995) 0.37(0.312, 0.463) 0.006
Low 114(27.7) 118(28.7) 1 1
Social withdrawal
High 69(16.8) 146(35.5) 0.24(0.159, 0.362) 0.27(0.156, 0.468) <0.001
Low 130(31.6) 66(16.1) 1 1
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carried out across 14 Europe countries (50.8%) [27] and a
systematic review reported by Gabriel et al. (47.4%) [28].
Even if the ways in which the participants’ experience
of stigma resistance toward each items were different, a
number of similarities were also reported. For example,
from South Africa 84% of respondents agreed or strongly
agreed with the item “people with mental illness make
important contributions to society” compared with
92.9% in this study [29]. Similar results also reported
from Tehran study toward each items of stigma resist-
ance [30]. These similarities may indicate their similar
effort to fight stigma.
Regarding the associated factors; those patients who par-
ticipated in the study from rural residences were about
seventy one times less likely to develop high stigma resist-
ance, [AOR = 0.29 (95% CI: 0.142, 0.594)] than those pa-
tients who participated from urban residences. This may
be due to the fact that people in urban areas were accessed
to different types of stigma reduction strategies such ascontact with the mentally ill patients, access for different
teaching media such as news paper and television as com-
pared to those lived in rural areas.
Those patients who had difficulties of adherence to their
antipsychotic medication were about seventeen times less
likely to develop high stigma resistance, [(AOR = 0.3, 95%
CI: 0.155, 0.542)] than those patients who adhere to their
antipsychotic medication. This may be due to fear of
stigma and discrimination; patients may reduced their ad-
herence to antipsychotic medication. Stigma may have im-
pact upon adherence to antipsychotic medication through
various psychological mechanisms such as loss of self-
esteem and self-efficacy, demoralization, hopelessness and
depression [9-12,23]. For example, almost half of all pa-
tients who were non-adherent to their medication attrib-
uted to discontinued because of stigma [24].
Those patients who experienced high internalized stigma
were about seventy six times less likely to develop high
stigma resistance, [(AOR = 0.24, 95% CI: (0.111, 0.530)]
than those patients who experienced low internalized
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sist or be unaffected by internalized stigma [23,25,28]
therefore; those patients may not build up their capacity to
counteract the devaluation, shame, secrecy and withdrawal
triggered by applying negative stereotypes to them in order
to play crucial role in fighting stigma and help their hope
of finding a fulfilling life in their recovery from mental ill-
ness and internalized stigma [23]. These findings support
the evidence for the role of stigma resistance as an import-
ant indication to fight internalized stigma.
Those patients who experienced high alienation were
about fifty times less likely to develop high stigma resist-
ance, [(AOR = 0.5, 95% CI: (0.270, 0.927)] than those pa-
tients who experienced low alienation. This is probably,
since alienation is the subjective experience of being less
than a full member of society [25,28] therefore; those pa-
tients may simply accept what the society’s have in mind
toward mental ill patients or they may not be psycho-
logically ready to fight against negative attitude of the
society toward them.
Those patients who experienced high stereotype en-
dorsement were about sixty three times less likely to de-
velop high stigma resistance, [AOR = 0.37 (95% CI: 0.31,
0.46)] than those patients who experienced low stereo-
type endorsement. This may be due to the fact that,
since stereotype endorsement is occurs when stereotype
agreement/when an individual endorses the common
public stereotypes (e.g., people with mental illness are
weak) and stereotype self-concurrence/when an individ-
ual applies the culturally internalized beliefs to him or
herself (e.g., I am weak because I have a mental illness)
[25]. This, in turn, yields decrements in self-esteem, self-
efficacy and the stigma resistance of individuals. In the
current study this can be evidenced by almost half of the
study participants were agreed or strongly agreed with
stereotype endorsement and more than half of the study
participants had low stigma resistance.
Those patients who experienced high social withdrawal
were about seventy three times less likely to develop high
stigma resistance, [(AOR = 0.27, 95% CI: (0.156, 0.468)]
than those patients who had low social withdrawal. This
may be due to fear of stigma and discrimination, conceal-
ment of one’s illness was a concern of the respondents. In
addition, withdrawal from social contacts, particularly by
those patients who suspected negative attitude may prac-
tice as means of stigma reduction strategy.
Strength of the study
This study is the first of its kind in Ethiopia that determined
the stigma resistance of individual with schizophrenia.
Limitations of the study
The lack of published literature in Ethiopia limits the
discussion of the findings. Recall and response biasesmight have occurred when completing the questionnaire.
Some important variables such as quality of life and sever-
ities of the symptoms were not assessed. In addition, some
of the independent variables were assessed with single
questions, for example treatment adherence and difficul-
ties of follow up adherence to their clinic appointments
that may lead some patients to respond improperly.
Conclusion
In this study, more than half of the study participants
had low stigma resistance. Rural residence, difficulties of
adherence to antipsychotic medication, high internalized
stigma, alienation and social withdrawal were factors sta-
tistically associated with low stigma resistance. These
findings provide evidence for the role of stigma resist-
ance as a viable target to fight internalized stigma and
improve the treatment adherence of people with schizo-
phrenia. Therefore participations in different social rela-
tionships such as befriending programs, family and peer
support groups are recommended particularly more at-
tentions are given for those coming from rural residence
in the clinical care setting to improve their adherence to
antipsychotic medication. Further researches with quali-
tative and quantitative study methods are also suggested,
in order to explore the relation of socio-demographic
and stigma resistance.
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